About Bilcare Research

Bilcare Research is an innovation-led solutions provider that partners with the global pharmaceutical and healthcare industry to improve patient healthcare outcomes. We endeavour to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

An R&D driven organization, Bilcare Research focuses on developing cutting-edge solutions that enable the pharmaceutical industry to realize significant qualitative and measurable cost and time benefits in the 'drug discovery to market' value chain.

Bilcare Research has a global footprint with modern manufacturing and R&D plants located across U.S., Europe, India and Singapore. We work with leading pharmaceutical companies across the globe to address their challenges. This includes not only bolstering the drug discovery pipeline through innovative products, processes and services, but also improving the efficacy of pharmaceuticals and drug delivery through innovative solutions in packaging. Our novel brand protection and management technologies aim to ensure that safe and genuine medicines reach the hands of consumers.

We, at Bilcare Research, drive our continual innovation process with a unilateral focus on addressing the key concerns and challenges of the pharmaceutical and healthcare industries, more particularly the 5Cs - Counterfeit, Compliance, Communication, Convenience and Cost. We firmly believe that our solutions contribute not only to addressing these crucial challenges but also seamlessly integrate with their core objectives of enhancing business growth and improving Health Outcomes.

At a glance

• Founded in 1993 by Mohan Bhandari, Bilcare Ltd. is listed on Bombay Stock Exchange (BSE)
• Three defined business areas - Pharma Packaging & Research, Global Clinical Supplies and Bilcare Technologies for brand authentication and security
• A global workforce of 1000+ employees spread across India, Singapore, Germany, Italy, the US and the UK.
• Operations spread across 4 continents with more than 500 pharma customers globally
• Manufacturing plants and R&D centres located in Pune, Singapore, US and UK
• Revenues of Rs. 2,286.58 crores